Ocuscreen is an AI-powered solution for fast and easy diagnosis of Diabetic Retinopathy. It assists ophthalmologists in the screening of diabetic patients for DR, allowing them to detect the disease at very early stages and prevent blindness for thousands of patients at risk.
Ocuscreen
Ocuscreen
Ocuscreen
AI-powered Diabetic Retinopathy Diagnosis in Seconds
Diabetic Retinopathy Detection Platform:
Cloud / on-premise options
Fully
automated
Result
in 3 seconds
High tolerance
to image quality
There are 400+ mln patients with diabetes worldwide
Diabetic Retinopathy is the second cause of disability among diabetic patients after glaucoma
Most countries face the challenge of regular screening of diabetic patients for DR as a sight-threatening condition
Diabetic Retinopathy Worldwide
The risk of developing DR ranges from 30 to 54.6% depending on the stage of diabetes
* on APTOS dataset
Imageability — percent of images which ocuscreen recognises as gradable (done with sufficient quality)
(True Negative Rate) refers to the proportion of those who received a negative result on this test out of those who do not actually have the condition (when judged by the ‘Gold Standard’)
Specificity
(True Positive Rate) — refers to the proportion of those who received a positive result on this test out of those who actually have the condition (when judged by the ‘Gold Standard’)
Sensitivity
Key Metrics
How it works
Explore highlighted regions of interest
Analyze picture with Ocuscreen
Take a photo with a fundus camera
Want to learn more about Ocucreen?
Highlights regions for doctor’s close attention
Generates a PDF report with a suggested diagnosis
Identifies left/right eye
Ocuscreen
Instant photo quality check: defines if the photo is gradable/ non-gradable in less than 1 second
Diabetes centers
Primary care units
Optometric offices
Clinics / hospitals comprising an ophthalmology department
Fundus camera manufacturers
Private medical labs
Who is it for:
Ocuscreen AI algorithms are able to recognize dust and dead pixels on camera optics and exclude them from the diagnosis
1
Higher economic efficiency and diagnosis accuracy as compared to a human grader
2
Ocuscreen may be used a clinical decision support system or a DR screening tool
3
Technology Advantages
Ocuscreen Team
Our international team combines the expertise of skilled data scientists, healthcare and business administration professionals.
  • Max Usov
    CTO
  • Arjan Hejl
    Director, Netherlands
Ocuscreen Team
Our international team combines the expertise of skilled data scientists, healthcare and business administration professionals.
  • Max Usov
    CTO
  • Arjan Hejl
    Director, Netherlands
Become a partner
Become a partner
© 2006-2021 Enbisys
The Netherlands:
Oosteinde 34, 2361 HE Warmond
info@enbisys.com | +31 85 06 537 42
We are flexible in terms of the potential business model for our solution. Contact us to disuss possible options of cooperation
Become a partner